CHEK1 and neoplasm: Furthermore, Chk1 heterozygosity was shown to synergize with p53 haplo-insufficiency in promoting breast cancer24 and significantly accelerated the onset and tumor incidence in Chk2−/− mice that most frequently developed lymphoma25.